- Home
- ELTX vs VOR Comparison
ELTX vs VOR Comparison
Compare ELTX & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELTX
- VOR
- Stock Information
- Founded
- ELTX 2011
- VOR 2015
- Country
- ELTX United States
- VOR United States
- Employees
- ELTX N/A
- VOR N/A
- Industry
- ELTX Biotechnology: Pharmaceutical Preparations
- VOR Biotechnology: Pharmaceutical Preparations
- Sector
- ELTX Health Care
- VOR Health Care
- Exchange
- ELTX Nasdaq
- VOR Nasdaq
- Market Cap
- ELTX 49.7M
- VOR 59.3M
- IPO Year
- ELTX 2021
- VOR 2021
- Fundamental
- Price
- ELTX $4.93
- VOR $0.79
- Analyst Decision
- ELTX Strong Buy
- VOR Strong Buy
- Analyst Count
- ELTX 3
- VOR 7
- Target Price
- ELTX $9.50
- VOR $11.36
- AVG Volume (30 Days)
- ELTX 28.6K
- VOR 633.4K
- Earning Date
- ELTX 11-13-2024
- VOR 11-07-2024
- Dividend Yield
- ELTX N/A
- VOR N/A
- EPS Growth
- ELTX N/A
- VOR N/A
- EPS
- ELTX N/A
- VOR N/A
- Revenue
- ELTX N/A
- VOR N/A
- Revenue This Year
- ELTX N/A
- VOR N/A
- Revenue Next Year
- ELTX N/A
- VOR N/A
- P/E Ratio
- ELTX N/A
- VOR N/A
- Revenue Growth
- ELTX N/A
- VOR N/A
- 52 Week Low
- ELTX $2.96
- VOR $0.63
- 52 Week High
- ELTX $11.45
- VOR $3.14
- Technical
- Relative Strength Index (RSI)
- ELTX 50.12
- VOR 46.96
- Support Level
- ELTX $4.95
- VOR $0.75
- Resistance Level
- ELTX $5.48
- VOR $0.82
- Average True Range (ATR)
- ELTX 0.32
- VOR 0.08
- MACD
- ELTX 0.00
- VOR -0.01
- Stochastic Oscillator
- ELTX 27.27
- VOR 20.59
About ELTX Elicio Therapeutics Inc.
Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking. Elicio is engineering lymph node-targeted AMPlifiers, immunomodulators, adjuvants, and vaccines for an array of aggressive cancers. It has developed its cancer vaccine product candidates to target biologically validated tumor mutation drivers using known neoantigens.
About VOR Vor Biopharma Inc.
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VOR33.